Articles
Notes from the evidence
Plain-language, sourced explainers — how to read a health claim, what the medicines actually do, and living with them. The Evidence Library grades the hard questions; this is where we think out loud, honestly.
evidence-journey
Protecting muscle on a GLP-1 when you can't just "go lift"
Protecting muscle on a GLP-1 when you can't just "go lift"
Every muscle-preservation guide says "eat protein and lift weights" — and quietly assumes a gym and a body that cooperates. If your knees don't, here's what the evidence actually supports, and where it honestly runs out.
Read →evidence-journey
GLP-1s After 60: Weight Loss Holds Up — Muscle and Bone Are the Real Story
GLP-1s After 60: Weight Loss Holds Up — Muscle and Bone Are the Real Story
Almost everyone over 60 arrives with the same belief: the weight comes off slower because I'm older. The age-subgroup data don't support it — and point to a more useful conversation about muscle, bone, and what to track instead of the scale.
Read →evidence-journey
The Food Noise Came Back on Maintenance: What It Means (and What It Doesn't)
The Food Noise Came Back on Maintenance: What It Means (and What It Doesn't)
You hit goal weight, you're still taking the drug, and the hum of thinking about food is back. The fear is always "it stopped working" or "I failed." The maintenance trials point to a third, calmer answer.
Read →access
When you're forced off a GLP-1: coverage loss, shortages, and what actually happens next
When you're forced off a GLP-1: coverage loss, shortages, and what actually happens next
Most people pushed off a GLP-1 didn't fail the drug — a formulary decision, a shortage, or a side effect pulled the trigger. In randomized trials, roughly two-thirds of lost weight returns within a year of stopping semaglutide. That's disease recurrence, not weakness — and there is an ordered set of moves to make before panic makes them for you.
Read →evidence-journey
The Scale Barely Moved — But Is It Still Working? Response Beyond the Number
The Scale Barely Moved — But Is It Still Working? Response Beyond the Number
Your weight has barely budged this month, but your last labs looked better than they have in years. So which one is telling the truth about whether the drug is working? Often both — and the scale is the least of them.
Read →Myths & headlines
Do GLP-1s cause — or prevent — cancer? What the evidence says
Do GLP-1s cause — or prevent — cancer? What the evidence says
One camp says these drugs cause cancer; another says they prevent it. On today's evidence both overreach: no overall rise, a rodent-based thyroid warning humans haven't confirmed, and early signals of lower risk for some obesity-linked cancers — association, not proof, in every direction.
Read →Myths & headlines
GLP-1s beyond weight loss: what's proven, what's hype
GLP-1s beyond weight loss: what's proven, what's hype
In 18 months the same drug class was FDA-approved to cut heart attacks, protect kidneys, treat sleep apnea, and calm a diseased liver — and, in the same stretch, flunked its biggest test in Alzheimer's. Neither 'miracle drug' nor 'just weight loss' survives the evidence. Here's each use, graded on its own rung.
Read →Living with it
Dropped by your insurer mid-GLP-1: the 2026 coverage cliff
Dropped by your insurer mid-GLP-1: the 2026 coverage cliff
In 2025–2026, pharmacy benefit managers, employers, and Medicare rules quietly cut GLP-1 coverage for weight loss. If your refill got denied, you didn't do anything wrong — the decision happened at the policy layer, and the appeal system is a defined legal right with deadlines.
Read →Myths & headlines
'Did you even try?' The science that dismantles the 'easy way out'
'Did you even try?' The science that dismantles the 'easy way out'
'You didn't earn it.' The insult assumes weight is held in place by willpower. Decades of physiology say the body actively defends a higher weight — slowing metabolism for years and keeping hunger hormones switched on. That biology is exactly what these drugs treat.
Read →Living with it
When a GLP-1 barely works: non-responders, honestly
When a GLP-1 barely works: non-responders, honestly
In the big trials, roughly 1 in 6 to 1 in 10 people lost less than 5% of their weight on a GLP-1 — a real minority the ads skip. Barely responding usually isn't a character flaw or a life sentence. Here's the real version.
Read →The medicines
GLP-1 pills vs shots: what the difference actually is
GLP-1 pills vs shots: what the difference actually is
There's finally a real GLP-1 pill shelf, not just injections. In separate trials the shots — tirzepatide most of all — have led on weight loss, but no study has ever put a pill against a shot head-to-head. The choice is a trade-off, not a ranking.
Read →Living with it
How long does a GLP-1 take to work? The honest timeline
How long does a GLP-1 take to work? The honest timeline
A GLP-1 runs on two clocks. Appetite and "food noise" usually quiet within days to a few weeks; the scale is a lagging indicator that keeps falling for roughly six to nine months as the dose is stepped up. A slow start rarely means it isn't working.
Read →Myths & headlines
Nature's Ozempic? Berberine, gelatin water & fibermaxxing, graded
Nature's Ozempic? Berberine, gelatin water & fibermaxxing, graded
Berberine, gelatin water, and fibermaxxing get sold as 'nature's Ozempic.' None of them is a GLP-1. The best trials put them somewhere between zero and a couple of pounds — against roughly 15–20% for the drugs. Here's each viral claim, graded.
Read →Living with it
Is Ozempic making my hair fall out? The honest answer
Is Ozempic making my hair fall out? The honest answer
Hair in the drain after starting a GLP-1 is real, and it's right there on the FDA label — but at low single-digit rates, and it's almost certainly telogen effluvium: the temporary shedding that follows any fast weight loss and usually regrows. Here's the honest, graded picture.
Read →Myths & headlines
'Ozempic teeth': dry mouth, acid & dental risk, graded
'Ozempic teeth': dry mouth, acid & dental risk, graded
"Ozempic teeth" isn't a diagnosis or a labeled side effect — it's a viral name for a chain of plausible oral effects. The GI links are real and measured; the dental damage in actual GLP-1 users has never been counted. Here's each link, graded.
Read →Myths & headlines
"Ozempic personality": what GLP-1s really do to your mood
"Ozempic personality": what GLP-1s really do to your mood
In 2026 the FDA removed the suicide warning from these drugs — and separately, people online describe going flat, numb, or joyless on them. Both things are true at once. Here's how to hold them together honestly.
Read →Living with it
Get more from your next GLP-1 clinician visit
Get more from your next GLP-1 clinician visit
Your clinician has maybe ten minutes. These are the notes, questions, and one-page summary that make them count — so you leave with answers, not more to-dos.
Read →Living with it
GLP-1s and exercise: why resistance training earns its place
GLP-1s and exercise: why resistance training earns its place
Fast weight loss always sheds some muscle with the fat. Lifting things — not the medicine — is what protects it. Here's what the evidence actually supports, framed as a floor, not a workout plan.
Read →Living with it
Non-scale victories: how to tell it's working when the scale won't
Non-scale victories: how to tell it's working when the scale won't
The scale is one blunt number that swings with water and hormones. These are the quieter, often more honest signs progress is real — and none of them require weighing yourself at all.
Read →Method
How we grade evidence: the 8-rung ladder in plain English
How we grade evidence: the 8-rung ladder in plain English
Two claims can sound identical and deserve opposite amounts of trust. The Evidence Ladder is how we tell them apart — and how you can too.
Read →Method
Why we sell you nothing but a book
Why we sell you nothing but a book
Almost every GLP-1 site makes money when you click, buy, or hand over your details. We made a deliberate choice not to. Here's why that changes what we can tell you.
Read →Myths & headlines
How to read a GLP-1 headline without getting fooled
How to read a GLP-1 headline without getting fooled
“Ozempic linked to…” headlines are engineered to alarm or amaze. Five questions tell you, in under a minute, whether there's anything underneath.
Read →
No articles match — try a different word or category.